

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Ko te Sofosbuvir he rongoā rongoā antiviral i hangaia hei rongoā i te hepatitis C, he mate viral e pā ana ki tō ate. E mahi ana tēnei rongoā mā te aukati i te huaketo mai i te hanga i ngā kape o ia anō, e whai wāhi ana te pūnaha ārai mate o tō tinana ki te whakawātea i te mate katoa.
Mēnā kua tāutuhia koe ki te hepatitis C, tērā pea kei te pōuri koe i ngā pātai me ngā āwangawanga. Ko te rongo pai ko te mea kua hurihia e te sofosbuvir te rongoā hepatitis C, e tuku ana i ngā reiti rongoā i runga ake i te 95% ka whakamahia hei wāhanga o te rongoā whakakotahi. Me haere tātou i ngā mea katoa e hiahia ana koe ki te mōhio mō tēnei rongoā e huri ana i te ora.
Ko te Sofosbuvir he rongoā antiviral tika (DAA) e whai ana i te huaketo hepatitis C. No te akomanga rongoā e kiia nei ko te aukati i te polymerase nucleotide, he uaua tēnei, engari ko te tikanga he aukati i te huaketo mai i te whakaputa uri i tō tinana.
Kāore i rite ki ngā rongoā hepatitis C tawhito i hiahiatia ai ngā werohanga mamae me te pānga taha nui, ka tae mai te sofosbuvir hei papa ngāwari ki te tango. I whakaaetia te rongoā e te FDA i te tau 2013, ā, mai i tērā wā kua āwhina i te miriona o ngā tāngata ki te rongoā i tō rātou mate hepatitis C.
Ko te mea e tino whai hua ana te sofosbuvir ko te mea e mahi tika ana ki te huaketo tonu, kaua ki te whakanui noa i te urupare o tō pūnaha ārai mate. Ko tēnei huarahi whāinga te tikanga he iti ake ngā pānga taha me ngā reiti angitu nui ake i ngā rongoā o mua.
Ko te Sofosbuvir te mea nui e whakamahia ana hei rongoā i te mate huaketo hepatitis C (HCV) i ngā pakeke. Ka tohua e tō tākuta hei wāhanga o te rongoā whakakotahi, kaua rawa hei rongoā takitahi, nā te mea ko te whakamahi i ngā rongoā maha i te taha tahi ka aukati i te huaketo mai i te whakawhanake i te aukati.
He whai hua te rongoā nei ki ngā momo ira nui e ono o te huaketo hepatitis C. Mā tō tākuta e whakatau tō momo ira motuhake mā ngā whakamātautau toto, ā, mā tērā e āwhina i a rātou ki te whiriwhiri i te huinga rongoā pai rawa atu mō tō keehi. Ko tēnei huarahi whaiaro e tino whakapai ake ana i ō tūponotanga ki te whakatutuki i te urupare virologic pumau, he kupu rongoā tēnei mō te whakaora.
I ētahi wā, ka whakamahia pea te sofosbuvir hei rongoā i te hepatitis C i roto i ngā tāngata e rua ana te hepatitis C me te mate HIV. Kua nui te rangahau i te rongoā nei i roto i tēnei taupori, ā, e whakaatu ana i ngā hua pai rawa atu ina whakamahia tahi me ngā rongoā HIV e tika ana.
Ka mahi te sofosbuvir mā te whakararu i te kaha o te huaketo hepatitis C ki te whakaputa anō i roto i ō pūtau ate. E hiahia ana te huaketo ki tētahi enzyme motuhake e kīia ana ko te NS5B polymerase ki te hanga i ngā tārua o ōna rauemi ira, ā, ka aukati te sofosbuvir i tēnei enzyme kia kore e tika te mahi.
Whakaarohia me te mea e kuhu ana i tētahi kī i roto i te mīhini tārua o te huaketo. Ki te kore e taea te whakaputa anō, ka mate haere ngā huaketo e noho ana i roto i tō pūnaha i te āhua tūturu, i te wā e kore ai e hangaia ētahi mea hou hei whakakapi i a rātou. Ko te tikanga, ka roa tēnei tukanga i ētahi wiki ki ētahi marama, i runga i tō āhuatanga motuhake.
Hei rongoā antiviral e mahi tika ana, e kiia ana ko te sofosbuvir he rongoā kaha, he tino whai hua. He arai nui tōna ki te aukati, ko te tikanga he uaua ki te huaketo te whakawhanake i ngā huarahi hei wikitoria i ngā pānga o te rongoā. Ko tēnei kaha te take i te nuinga o te wā ko te tūāpapa o te maha o ngā huinga rongoā hepatitis C.
Tangohia te sofosbuvir kia rite ki tā tō tākuta i whakarite ai, te tikanga kotahi papa 400mg i te rā kotahi. Ka taea e koe te tango me te kore kai, me te kai rānei, ahakoa e kite ana ētahi tāngata mā te tango me te kai e āwhina ana ki te whakaiti i te pōpō o te puku.
Horomia te papa katoa me te karaihe wai. Kaua e kuru, e ngaungau, e wawahi ranei i te papa, na te mea ka pa tenei ki te ahua o te rongoa e uru ana ki roto i to punaha. Whakamātauria ki te tango i tō horopeta i te wa kotahi i ia rā kia mau tonu ai te taumata o te rongoa i roto i ō toto.
Mena kei te tango koe i te sofosbuvir hei wāhanga o te rongoa whakakotahi, tera pea ka hiahia koe ki te tango i nga papa maha i nga wa rereke puta noa i te ra. Ka hoatu e tō kaiwhakarato hauora he waarangi taipitopito ki a koe, ā, he mea nui kia whai tika koe. Ko etahi rongoa whakakotahi ka tae mai i roto i nga papa kotahi kei roto nga raau taero maha, ka ngawari ake ai to tikanga.
Ko te roa o te maimoatanga noa me te sofosbuvir kei waenga i te 8 ki te 24 wiki, i runga i ō āhuatanga motuhake. Ko te nuinga o nga tangata e mate ana i te hepatitis C genotype 1, 2, 3, 4 ranei ka tango i te rongoa mo te 12 wiki ina honoa ki etahi atu rongoa antiviral tika.
Kei runga i nga mea maha te roa o to maimoatanga ka ata whakaarohia e to taakuta. Kei roto i enei ko to hepatitis C genotype, mena kua rongoatia koe i mua, te whānuitanga o te kino o te ate, me te mea kei a koe etahi atu mate hauora penei i te mate tahi HIV, i nga raruraru whatukuhu ranei.
Ko nga tangata e mate ana i te cirrhosis (te kiko ate) ka hiahia pea ki nga akoranga maimoatanga roa, i etahi wa ka toro atu ki te 24 wiki. Ka aroturukihia e tō tākuta tō ahunga whakamua mā te whakamātautau toto i nga wa katoa, ā, ka whakatika pea i te roa o tō maimoatanga i runga i te pai o tō urupare ki te rongoa.
Ko te nuinga o nga tangata e pai ana ki te sofosbuvir, ina koa ka whakatauritea ki nga maimoatanga hepatitis C tawhito. Ko nga paanga taha he ngawari noa, he whakahaere, ahakoa he rereke te wheako o te katoa.
Anei nga paanga taha tino noa ka pa ki a koe, ā, he mea whakahihiri ki te mohio he iti noa iho, karekau ranei he paanga taha ki te nuinga o nga tangata:
Ko ēnei pānga taha noa ka pai ake i te wā e urutau ana tō tinana ki te rongoā, i roto i ngā wiki tuatahi o te rongoā. Ki te pōraru ana, ka taea e tō tākuta te whakaatu i ngā huarahi hei whakahaere i a rātou.
He pānga taha anō he iti noa iho engari he nui ake te kino e hiahia ana kia tere te rongoā. Ahakoa he onge ēnei, he mea nui kia mōhio koe ki a rātou:
Ki te pā ana ki a koe ēnei tohu nui, whakapā atu ki tō kaiwhakarato hauora tonu. Kia mahara he onge ngā pānga taha nui, ā, kei te mātakitaki tata tō rōpū rongoā i a koe i te wā o te rongoā.
He haumaru te Sofosbuvir mō te nuinga o ngā pakeke e mate ana i te hepatitis C, engari he wāhi ka whiriwhiri tō tākuta i tētahi huarahi rongoā rerekē. Ko ngā tāngata e raru ana i ngā pūkahukahu nui pea me whakatika te horopeta, me tango rongoā rerekē rānei.
Me kōrero koe ki tō tākuta mō ngā rongoā katoa e tango ana koe i tēnei wā, tae atu ki ngā rongoā kore-whakahaere me ngā tāpiringa. Ka taea e te Sofosbuvir te pā ki ētahi rongoā, ina koa ko ētahi rongoā manawa pēnei i te amiodarone, ka taea te whakaiti i te tere o te manawa.
Mēnā kei te hapū koe, kei te whakamahere rānei koe kia hapū, kōrerohia tēnei ki tō tākuta tonu. Ahakoa kāore anō a sofosbuvir i whakaatu i ngā pānga kino i te wā e hapū ana, he maha ngā wā e whakamahia ana i roto i te huinga rongoā kē atu, ā, tērā pea kāore i te haumaru mō ngā pēpi e tipu ana. Ka āwhina tō tākuta i a koe ki te whakatau i ngā painga me ngā tūponotanga.
Ko ngā tāngata e pā ana ki ētahi mate ngākau, tērā pea me mātakitaki motuhake i te wā e rongoā ana, ina koa kei te tango rongoā rātou mō ngā raruraru o te manawataki. Ka arotake tō tākuta i tō hītori hauora katoa kia mōhio ai he pai te sofosbuvir mōu.
Ko te ingoa pūmau mō te sofosbuvir ko Sovaldi, i hangaia e Gilead Sciences. Koinei te putanga tuatahi o te rongoā i whakaaetia e te FDA, ā, kei te whānui tonu te whakahau i tēnei rongoā i tēnei rā.
Tērā pea ka kitea hoki e koe te sofosbuvir hei wāhanga o ngā rongoā huinga e uru ana ki te maha o ngā rongoā hepatitis C i roto i te papa kotahi. Kei roto i ēnei ko Harvoni (sofosbuvir me ledipasvir), Epclusa (sofosbuvir me velpatasvir), me Vosevi (sofosbuvir me velpatasvir me voxilaprevir).
Kei te wātea ngā putanga whānui o te sofosbuvir i ētahi whenua, ā, ka taea e tēnei te whakanui ake i te utu o te rongoā. Heoi anō, he rerekē te wātea i te wāhi, ā, ka whakahau tō tākuta i te putanga e tika ana mō tō āhuatanga me tō wāhi.
Ahakoa e whakaarohia ana ko te sofosbuvir te tūāpapa o te nuinga o ngā rongoā hepatitis C, kei reira ētahi atu kōwhiringa antiviral e mahi tika ana. Tērā pea ka whakaaro tō tākuta ki ngā kōwhiringa kē atu mēnā he āhuatanga hauora motuhake ō koe, mēnā rānei kāore te sofosbuvir i te pai mōu.
Ko ngā tikanga rongoā kē atu tērā pea ko ngā rongoā pēnei i te glecaprevir/pibrentasvir (Mavyret) rānei, ngā huinga kore sofosbuvir rānei mō ngā tāngata e pā ana ki te mate tākihi nui. Ka taea e ēnei kōwhiringa kē atu te whai hua pērā i ngā rongoā e hāngai ana ki te sofosbuvir ina whiriwhiria tika mō tō āhuatanga.
Ko te whiriwhiri i waenga i ngā momo rongoā rerekē e whakawhirinaki ana ki ngā āhuatanga pēnei i tō momo ira o te hepatitis C, te hauora o te ate, ētahi atu āhuatanga hauora, me ngā pānga rongoā pea. Mā tō tākuta mātanga hepatitis C e arotake ēnei āhuatanga katoa hei tūtohu i te mahere rongoā pai rawa atu mōu.
He pai ake ngā rongoā e hāngai ana ki te Sofosbuvir i ngā rongoā tawhito e hāngai ana ki te interferon i te nuinga o ngā huarahi. He nui ake ngā reiti whakaora, he poto ake te wā rongoā, ā, he pai ake te whakahaere i ngā pānga taha.
I hiahiatia e ngā rongoā e hāngai ana ki te interferon ngā werohanga ia wiki, ā, i puta mai ngā tohumate rite ki te rewharewha, te pōuri, me ētahi atu pānga taha kino i kore ai te nuinga o te tangata e whakaoti i te rongoā. Ko ngā mahere rongoā Sofosbuvir he waha katoa, ka tangohia hei papa noa, me ngā pānga taha ngawari me te whakahaere mō te nuinga o te tangata.
E whakaatu marama ana ngā reiti angitu i te pūrākau. Ahakoa ko ngā rongoā e hāngai ana ki te interferon he reiti whakaora o te 40-70% i runga i te momo ira o te hepatitis C, ka tutuki i ngā huinga e hāngai ana ki te sofosbuvir ngā reiti whakaora o te 95-99% puta noa i ngā momo ira katoa. Kua hurihia e tēnei whakapai ake nui te hepatitis C mai i te mate tawhito, te mate haere ki tētahi āhuatanga ka taea te rongoā mō te nuinga o te tangata.
Ka taea te whakamahi i te Sofosbuvir i runga i te haumaru mō te tāngata e mate ana i te whatumanawa ngawari ki te āhua, ahakoa me āta aroturuki tō tākuta i a koe. Mō te tāngata e mate ana i te whatumanawa kino, i te hunga rānei e haere ana i te dialysis, ka kōwhiri pea tō tākuta i ētahi atu rongoā, ka whakatika rānei i tō mahere aroturuki.
Ka tirohia tō mahi whatumanawa i mua i te tīmatanga o te rongoā, ā, ka aroturukihia puta noa i te akoranga o te rongoā. E whakarite ana tēnei aroturuki tupato i te mahi whai hua o te rongoā i te wā e tiaki ana i tō hauora whatumanawa.
Mēnā ka inu koe i te nui atu i tō horopeta kua whakaritea, whakapā atu ki tō tākuta, ki te pokapū whakahaere paitini rānei i te wā tonu. Ahakoa he onge te nui rawa o te sofosbuvir, he mea nui kia whiwhi tohutohu hauora tonu.
Kaua e ngana ki te utu mā te peke i tō horopeta e whai ake nei. Engari, whai i ngā tohutohu a tō tākuta, ka hoki ki tō hōtaka horopeta i te wā tika. Kia mau ki ngā mea i pā, kia taea ai e koe te kōrero ki tō kaiwhakarato hauora.
Mēnā kua ngaro i a koe tētahi horopeta, ā, kei roto i te 18 hāora o tō wā tonu, inumia te horopeta i ngaro i te wā e mahara ana koe. Mēnā kua roa atu i te 18 hāora, pekehia te horopeta i ngaro, ka inu i tō horopeta e whai ake nei i te wā tika.
Kaua rawa e inu i ngā horopeta e rua i te wā kotahi hei utu mō tētahi horopeta i ngaro. Ka piki ake pea tō tūponotanga ki ngā pānga taha me te kore e pai ake te whai huatanga o te rongoā. Mēnā kei te ngaro auau koe i ngā horopeta, kōrerohia ki tō tākuta ngā rautaki hei āwhina i a koe ki te mahara.
Kati anake te inu i te sofosbuvir i te wā e kī ana tō tākuta ki a koe, ahakoa kei te pai ake koe. He mea nui te whakaoti i te akoranga katoa o te rongoā hei whakarite kia whakakorea katoatia te huaketo i tō pūnaha.
Ko te whakamutu wawe i te rongoā ka puta he rahunga rongoā, ā, ka taea e te huaketo te whakawhanake i te ātete ki te rongoā. Ka whakapūmau tō tākuta e kore e kitea te huaketo mā ngā whakamātautau toto i mua i te kī i te oti o tō rongoā.
He pai ake te karo i te waipiro katoa i te wā e inu ana i te sofosbuvir me te roanga o tō rongoā hepatitis C. Ka taea e te waipiro te whakapōrearea i te kino o te ate, ā, ka raru pea i te kaha o tō tinana ki te whakautu ki te rongoā.
Me hāpai tō ate i ngā tautoko katoa e taea ana e ia i te wā e whawhai ana ki te huaketo hepatitis C me te tukatuka i ngā rongoā. Mā te karo i te waipiro e whai wāhi pai ai tō ate ki te whakaora, ā, ka āwhina i te whakarite kia whai hua tō rongoā i te mea ka taea.
Get clear medical guidance
on symptoms, medications, and lab reports.